Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 101 - 150 of 759 results
- Intracavernous injection of prostaglandin E1 is effective in patients with erectile dysfunction not responding to phosphodiseterase 5 inhibitors.
- Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle.
- Effects of imatinib mesylate (Glivec) as a c-kit tyrosine kinase inhibitor in the guinea-pig urinary bladder.
- Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity.
- Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes.
- Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
- Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction.
- Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
- Sildenafil extends survival and graft function in a large animal lung transplantation model.
- Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
- Erectile dysfunction and statin treatment in high cardiovascular risk patients.
- Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim.
- Risk factors for urinary incontinence among middle-aged women.
- The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
- Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate.
- Multicenter phase III trial studying trospium chloride in patients with overactive bladder.
- The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition.
- Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.
- The functional effects of a c-kit tyrosine inhibitor on guinea-pig and human detrusor.
- Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review.
- Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation.
- Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
- Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding.
- Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.
- Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia.
- Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States.
- Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study.
- Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder.
- Expression of smoothelin in the normal and the overactive human bladder.
- Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland.
- Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
- Inhibitory mechanism of monensin on high K+-induced contraction in guniea-pig urinary bladder.
- Cardiovascular effects of KUR-1246, a new tetrahydronaphthalen derivative beta2-adrenoceptor agonist and a selective uterine relaxant.
- Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
- Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.
- Induced endometriosis in the baboon (Papio anubis) increases the expression of the proangiogenic factor CYR61 (CCN1) in eutopic and ectopic endometria.
- Pathophysiology of overactive bladder.
- Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
- Disruptive effects of overactive bladder and urge urinary incontinence in younger women.
- Pharmacologic management of overactive bladder: practical options for the primary care physician.
- Management of overactive bladder and urge urinary incontinence in the elderly patient.
- Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs.
- Suppression of bladder reflex activity in chronic spinal cord injured cats by activation of serotonin 5-HT1A receptors.
- Alternatively spliced neuronal nitric oxide synthase mediates penile erection.
- Furosemide use and hospitalization for benign prostatic hyperplasia.
- Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.
- Obstructive primary bladder neck disease: evaluation of the efficacy and safety of alpha1-blockers.
- Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia.
- Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.
- Assessment of sexual dysfunction in patients with benign prostatic hyperplasia.